| Citation Matrix | Glossary HistCite Guide |
| Gene expression profiling predicts clinical outcome of breast cancer van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH NATURE 415 (6871): 530-536 JAN 31 2002 and the papers citing them. |
Nodes: 336,
Authors: 1598,
Sources: 171,
Outer References: 11018
Collection span: 2002 - 2003
LCSb: 105 (31.25%) nodes before 2003
(1 years)
LCSe: 231 (68.75%) nodes after 2002
(1 years)
View: Bibliometric. Sorted by LCSb.
Page 2: 1 2
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
|---|---|---|---|---|---|---|---|---|---|
| 301 | 2 | 27 | 301 2003 ONCOGENE 22(36):5572-5578
Logarajah S; Hunter P; Kraman M; Steele D; Lakhani S; Bobrow L; Venkitaraman A; Wagner S BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation | 0 | 0.00 | 0 | 0.00 | 0 | |
| 302 | 3 | 123 | 302 2003 ONCOGENE 22(42):6497-6507
Russo G; Zegar C; Giordano A Advantages and limitations of microarray technology in human cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 303 | 1 | 136 | 303 2003 ONCOGENE 22(42):6570-6578
Menard S; Pupa SM; Campiglio M; Tagliabue E Biologic and therapeutic role of HER2 in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 304 | 2 | 50 | 304 2003 ONCOGENE 22(46):7155-7169
Jechlinger M; Grunert S; Tamir IH; Janda E; Ludemann S; Waerner T; Seither P; Weith A; Beug H; Kraut N Expression profiling of epithelial plasticity in tumor progression | 0 | 0.00 | 0 | 0.00 | 0 | |
| 305 | 3 | 39 | 305 2003 ONCOGENE 22(48):7702-7710
Mor O; Nativ O; Stein A; Novak L; Lehavi D; Shiboleth Y; Rozen A; Berent E; Brodsky L; Feinstein E; Rahav A; Morag K; Rothenstein D; Persi N; Mor Y; Skaliter R; Regev A Molecular analysis of transitional cell carcinoma using cDNA microarray | 0 | 0.00 | 0 | 0.00 | 0 | |
| 306 | 2 | 132 | 306 2003 ONCOGENE 22(53):8581-8589
Altieri DC Survivin, versatile modulation of cell division and apoptosis in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 307 | 2 | 32 | 307 2003 ONCOLOGIST 8(3):252-258
Pusztai L; Ayers M; Stec J; Hortobagyi GN Clinical application of cDNA microarrays in oncology | 0 | 0.00 | 3 | 3.00 | 0 | |
| 308 | 2 | 60 | 308 2003 ONKOLOGIE 26(5):438-445
Thomssen C; Janicke F; Harbeck N Clinical relevance of prognostic factors in axillary node-negative breast cancer | 0 | 0.00 | 1 | 1.00 | 0 | |
| 309 | 1 | 44 | 309 2003 PHARMACOGENOMICS 4(3):321-330
Brock TP; Valgus JM; Smith SR; Summers KM Pharmacogenomics: implications and considerations for pharmacists | 0 | 0.00 | 0 | 0.00 | 0 | |
| 310 | 1 | 43 | 310 2003 PHYSIOLOGICAL GENOMICS 13(3):249-262
Ho M; Yang E; Matcuk G; Deng D; Sampas N; Tsalenko A; Tabibiazar R; Zhang Y; Chen M; Talbi S; Ho YD; Wang J; Tsao PS; Ben-Dor A; Yakhini Z; Bruhn L; Quertermous T Identification of endothelial cell genes by combined database mining and microarray analysis | 0 | 0.00 | 2 | 2.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 311 | 1 | 59 | 311 2003 PLANT PHYSIOLOGY 132(2):893-906
Provart NJ; Gil P; Chen WQ; Han B; Chang HS; Wang X; Zhu T Gene expression phenotypes of Arabidopsis associated with sensitivity to low temperatures | 0 | 0.00 | 1 | 1.00 | 0 | |
| 312 | 1 | 41 | 312 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(5):2532-2537
Hedenfalk I; Ringner M; Ben-Dor A; Yakhini Z; Chen Y; Chebil G; Ach R; Loman N; Olsson H; Meltzer P; Borg A; Trent J Molecular classification of familial non-BRCA1/BRCA2 breast cancer | 3 | 3.00 | 7 | 7.00 | 3 | |
| 313 | 1 | 23 | 313 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(10):5974-5979
Ma XJ; Salunga R; Tuggle JT; Gaudet J; Enright E; McQuary P; Payette T; Pistone M; Stecker K; Zhang BM; Zhou YX; Varnholt H; Smith B; Gadd M; Chatfield E; Kessler J; Baer TM; Erlander MG; Sgroi DC Gene expression profiles of human breast cancer progression | 3 | 3.00 | 9 | 9.00 | 3 | |
| 314 | 1 | 35 | 314 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(11):6347-6352
Semizarov D; Frost L; Sarthy A; Kroeger P; Halbert DN; Fesik SW Specificity of short interfering RNA determined through gene expression signatures | 0 | 0.00 | 12 | 12.00 | 0 | |
| 315 | 2 | 39 | 315 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(13):7737-7742
Schmidt-Kittler O; Ragg T; Daskalakis A; Granzow M; Ahr A; Blankenstein TJF; Kaufmann M; Diebold J; Arnholdt H; Muller P; Bischoff J; Harich D; Schlimok G; Riethmuller G; Eils R; Klein CA From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression | 1 | 1.00 | 3 | 3.00 | 1 | |
| 316 | 5 | 27 | 316 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8418-8423
Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lonning PE; Brown PO; Borresen-Dale AL; Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets | 2 | 2.00 | 5 | 5.00 | 2 | |
| 317 | 4 | 25 | 317 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(18):10393-10398
Sotiriou C; Neo SY; McShane LM; Korn EL; Long PM; Jazaeri A; Martiat P; Fox SB; Harris AL; Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study | 1 | 1.00 | 1 | 1.00 | 1 | |
| 318 | 2 | 18 | 318 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(19):10585-10587
Ferl GZ; Timmerman JM; Witte ON Extending the utility of gene profiling data by bridging microarray platforms | 0 | 0.00 | 0 | 0.00 | 0 | |
| 319 | 2 | 29 | 319 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(19):10931-10936
Porter D; Weremowicz S; Chin K; Seth P; Keshaviah A; Lahti-Domenici J; Bae YK; Monitto CL; Merlos-Suarez A; Chan J; Hulette CM; Richardson A; Morton CC; Marks J; Duyao M; Hruban R; Gabrielson E; Gelman R; Polyak K A neural survival factor is a candidate oncogene in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 320 | 1 | 37 | 320 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(20):11606-11611
Kleer CG; Cao Q; Varambally S; Shen RL; Ota L; Tomlins SA; Ghosh D; Sewalt RGAB; Otte AP; Hayes DF; Sabel MS; Livant D; Weiss SJ; Rubin MA; Chinnaiyan AM EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 321 | 1 | 11 | 321 2003 PROGRESS IN CHEMISTRY 15(5):436-438
Zhao XS The role played by chemical biology in the bio-chip technology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 322 | 1 | 66 | 322 2003 RECENT PROGRESS IN HORMONE RESEARCH, VOL 58 58():25-53
Copland JA; Davies PJ; Shipley GL; Wood CG; Luxon BA; Urban RJ The use of DNA microarrays to assess clinical samples: The transition from bedside to bench to bedside | 0 | 0.00 | 1 | 1.00 | 0 | |
| 323 | 2 | 9 | 323 2003 SCIENTIST ():22-24
Lewis R DNA expression profiling: A new lens on cancer - The seeds of spread may be sown early | 0 | 0.00 | 0 | 0.00 | 0 | |
| 324 | 1 | 99 | 324 2003 SEMINARS IN ONCOLOGY 30(4):23-36
Chakravarthy B; Pietenpol JA Combined modality management of breast cancer: Development of predictive markers through proteomics | 0 | 0.00 | 0 | 0.00 | 0 | |
| 325 | 1 | 107 | 325 2003 SEMINARS IN ONCOLOGY 30(5):38-48
Zhou BP; Hung MC Dysregulation of cellular signaling by HER2/neu in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 326 | 1 | 42 | 326 2003 SIGNAL PROCESSING 83(4):729-743
Bhattacharyya C; Grate LR; Rizki A; Radisky D; Molina FJ; Jordan MI; Bissell MJ; Mian IS Simultaneous classification and relevant feature identification in high-dimensional spaces: application to molecular profiling data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 327 | 1 | 7 | 327 2003 STRAHLENTHERAPIE UND ONKOLOGIE 179(10):715-716
Mross K Second malignancies following adjuvant chemotherapy: 6-Year results from a Belgian randomized study comparing cyclophosphamide, methotrexate und 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients | 0 | 0.00 | 0 | 0.00 | 0 | |
| 328 | 2 | 20 | 328 2003 THROMBOSIS AND HAEMOSTASIS 90(3):538-548
Look M; van Putten W; Duffy M; Harbeck N; Christensen IJ; Thomssen C; Kates R; Spyratos F; Ferno M; Eppenberger-Castori S; Sweep CGJF; Ulm K; Peyrat JP; Martin PM; Magdelenat H; Brunner N; Duggan C; Lisboa BW; Bendah PO; Quillien V; Daver A; Ricolleau G; Meijer-Van Gelder M; Manders P; Fiets WE; Blankenstein M; Broet P; Romain S; Daxenbichler G; Windbichler G; Cufer T; Borstnar S; Kueng W; Beex L; Klijn J; O'Higgins N; Eppenberger U; Janicke F; Schmitt M; Foekens J Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients | 0 | 0.00 | 0 | 0.00 | 0 | |
| 329 | 8 | 75 | 329 2003 TISSUE ANTIGENS 62(2):93-103
Boussioutas A; Haviv I Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines | 0 | 0.00 | 0 | 0.00 | 0 | |
| 330 | 1 | 21 | 330 2003 TOXICOLOGY LETTERS 140():145-148
Orphanides G Toxicogenomics: challenges and opportunities | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 331 | 1 | 34 | 331 2003 TRANSPLANTATION 75(8):1323-1330
Scherer A; Krause A; Walker JR; Korn A; Niese D; Raulf F Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies | 0 | 0.00 | 1 | 1.00 | 0 | |
| 332 | 1 | 87 | 332 2003 TRENDS IN BIOTECHNOLOGY 21(8):346-353
Bracco L; Kearsey J The relevance of alternative RNA splicing to pharmacogenomics | 0 | 0.00 | 0 | 0.00 | 0 | |
| 333 | 2 | 45 | 333 2003 TRENDS IN GENETICS 19(12):690-695
Potter JD Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs | 0 | 0.00 | 0 | 0.00 | 0 | |
| 334 | 1 | 65 | 334 2003 ULTRASTRUCTURAL PATHOLOGY 27(1):41-48
Castro P; David L; Soares P; Carneiro F; Fonseca E; Sobrinho-Simoes M Vascular invasion in thyroid and gastric carcinomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 335 | 1 | 42 | 335 2003 VIRCHOWS ARCHIV 443(1):57-66
Morawietz L; Gehrke T; Frommelt L; Gratze P; Bosio A; Moller J; Gerstmayer B; Krenn V Differential gene expression in the periprosthetic membrane: lubricin as a new possible pathogenetic factor in prosthesis loosening | 0 | 0.00 | 0 | 0.00 | 0 | |
| 336 | 1 | 61 | 336 2003 VIRCHOWS ARCHIV 443(4):508-517
Grutzmann R; Foerder M; Alldinger I; Staub E; Brummendorf T; Ropcke S; Li XZ; Kristiansen G; Jesnowski R; Sipos B; Lohr M; Luttges J; Ockert D; Kloppel G; Saeger HD; Pilarsky C Gene expression profiles of microdissected pancreatic ductal adenocarcinoma | 0 | 0.00 | 0 | 0.00 | 0 |
Page 2: 1 2
Generated by: HistCite(Vlad).
Version: 2004.01.07